Nava Zisapel
Founder chez Rad Biomed Accelerator Ltd.
Fortune : 46 M $ au 31/03/2024
Profil
Nava Zisapel is the founder of RADCOM Ltd.
(1985), Rad Biomed Accelerator Ltd.
(1992), and Neurim Pharmaceuticals Ltd.
(1991).
She holds the title of Chairperson at Rad Biomed Accelerator Ltd.
and Chief Executive Officer at Neurim Pharmaceuticals Ltd.
Ms. Zisapel's current job(s) include being a Director at Moebius Medical Ltd.
and Vectorious Medical Technologies Ltd.
She received her undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RADWARE LTD.
5,45% | 18/03/2024 | 2 467 843 ( 5,45% ) | 46 M $ | 31/03/2024 |
Postes actifs de Nava Zisapel
| Sociétés | Poste | Début |
|---|---|---|
Rad Biomed Accelerator Ltd.
 Rad Biomed Accelerator Ltd. Investment ManagersFinance Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel. | Founder | 01/01/1992 |
Neurim Pharmaceuticals Ltd.
 Neurim Pharmaceuticals Ltd. BiotechnologyHealth Technology Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel. | Chief Executive Officer | 01/01/1991 |
Moebius Medical Ltd.
 Moebius Medical Ltd. Medical SpecialtiesHealth Technology Moebius Medical Ltd. develops mechanical lubricants for reducing joint damage. It develops MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. The company was founded by Yaniv Dolev and Yechezkel Barenholz in 2008 and is headquartered in Tel Aviv, Israel. | Director/Board Member | - |
Vectorious Medical Technologies Ltd.
 Vectorious Medical Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel. | Director/Board Member | 12/03/2018 |
Anciens postes connus de Nava Zisapel
| Sociétés | Poste | Fin |
|---|---|---|
| RADCOM | Founder | - |
Formation de Nava Zisapel
| Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RADCOM | Technology Services |
| Entreprise privées | 4 |
|---|---|
Rad Biomed Accelerator Ltd.
Rad Biomed Accelerator Ltd. Investment ManagersFinance Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel. | Finance |
Moebius Medical Ltd.
Moebius Medical Ltd. Medical SpecialtiesHealth Technology Moebius Medical Ltd. develops mechanical lubricants for reducing joint damage. It develops MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. The company was founded by Yaniv Dolev and Yechezkel Barenholz in 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
Neurim Pharmaceuticals Ltd.
Neurim Pharmaceuticals Ltd. BiotechnologyHealth Technology Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel. | Health Technology |
Vectorious Medical Technologies Ltd.
Vectorious Medical Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel. | Electronic Technology |
